Compare PRPO & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | OESX |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Building Products |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 37.9M |
| IPO Year | 2000 | 2007 |
| Metric | PRPO | OESX |
|---|---|---|
| Price | $23.34 | $9.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 18.4K | ★ 63.4K |
| Earning Date | 05-12-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $24,049,000.00 | ★ $86,306,000.00 |
| Revenue This Year | N/A | $7.94 |
| Revenue Next Year | N/A | $13.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | 8.26 |
| 52 Week Low | $10.60 | $0.55 |
| 52 Week High | $33.63 | $18.64 |
| Indicator | PRPO | OESX |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 51.11 |
| Support Level | $21.71 | $8.51 |
| Resistance Level | $24.30 | $10.25 |
| Average True Range (ATR) | 1.11 | 0.69 |
| MACD | 0.26 | 0.02 |
| Stochastic Oscillator | 66.88 | 54.88 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.